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Abstract The amniotic fluid contains mesenchymal stem
cells (MSCs) and can be readily available for tissue engi-
neering. Regenerative treatments such as tissue engineer-
ing, cell therapy, and transplantation show potential in
clinical trials of degenerative diseases. Disease presenta-
tion and clinical responses in the Canis familiaris not only
are physiologically similar to human compared with other
traditional mammalian models but is also a suitable model
for human diseases. The aim of this study was to investi-
gate whether canine amniotic-fluid-derived mesenchymal
stem cells (cAF-MSCs) can differentiate into neural pre-
cursor cells in vitro when exposed to neural induction
reagent. During neural differentiation, cAF-MSCs pro-
gressively acquire neuron-like morphology. Messenger
RNA (mRNA) expression levels of neural-specific genes,
such as NEFL, NSE, and TUBB3 (bIII-tubulin) dramati-
cally increased in the differentiated cAF-MSCs after
induction. In addition, protein expression levels of nestin,
bIII-tubulin, and tyrosine hydroxylase remarkably
increased in differentiated cAF-MSCs. This study demon-
strates that cAF-MSCs have great potential for neural
precursor differentiation in vitro. Therefore, amniotic fluid
may be a suitable alternative source of stem cells and can
be applied to cell therapy in neurodegenerative diseases.
Keywords Amniotic fluids  Mesenchymal stem
cells  Degenerative diseases  Canine  Neural
precursor  Neurodegenerative diseases
Introduction
Prior to new medical treatments being approved for
regenerative medicine, clinical trials in animal models are
essential [1–3]. A number of researchers demonstrate that
Canis familiaris is a suitable model for human diseases [4,
5]. First, humans and dogs share the environmental life
pattern. Physiologically, disease presentation and clinical
symptom of the dog are much more similar to those of the
human compared with other traditional animal models, and
half of the canine diseases also belong to the group of
human diseases [5]. In the gene database of inherited dis-
orders and traits in [135 animal species, the dog has the
most important potential as an animal model for human
disease. Also, genomically, the genetic bases of disease
susceptibility, morphological variation, and behavioral
traits in dogs are significantly related with humans [6, 7].
Therefore, C. familiaris could be a promising animal
model for human regenerative medicine.
Mesenchymal stem cells (MSCs), generally known as
adult stem cells, were first isolated from postnatal bone
marrow [8], and its presence was identified in most mam-
malian tissues. Principal sources of MSCs are bone mar-
row, umbilical-cord blood, olfactory bulb, amniotic fluid
(AF), and Wharton’s jelly [9, 10]. As MSCs derived from
AF (AF-MSCs) have the potential for self-renewal and
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multipotency, they are also defined as stem cells. AF-MSCs
are easily isolated and demonstrate multiple differentiation
abilities [11–15]. AF-MSCs can be differentiated into
chondrogenic, adipogenic, osteogenic, myogenic, endo-
thelial, and neurogenic pathways, as with other MSC
sources [14, 16–22]. However, the difference between
embryonic stem cell and other MSC sources is that AF
stem cells have anti-inflammatory, low immunogenic
characteristics; display nontumorigenicity; and there are
few ethical issues surrounding their clinical application
[23–25]. For those reasons, AF cells have advantages as
materials for regenerative medicine.
Stem-cell-mediated therapy is a potential clinical treat-
ment for degenerative diseases. One type of degenerative
disease, neurological disorders, has limited treatment
because the condition of the nervous system cannot be
completely recovered after damage [26, 27]. To improve
treatment of neurodegenerative disorders, MSC-mediated
cell therapy and transplantation has been studied during the
past two decades [28]. Many researchers demonstrate that
stem cells can be differentiated into neural precursor cells
[18–20, 29, 30], and their use in clinical treatments has
been tried.
The aim of tis study was to investigate whether MSCs
originating from canine AF (cAF-MSCs) can differentiate
into neural precursor cells by using an identical neural
induction reagent. We also examined whether differenti-
ated neural cAF-MSCs have the characteristics of dopa-
minergic cells that secret the dopamine neurotransmitter to
prevent Parkinson’s disease.
Materials and methods
Unless otherwise stated, all chemicals used in this study
were purchased from Sigma-Aldrich Chemical Co. (USA).
The protocol for this research was approved by the
Research Ethics Committee of Chungnam National
University.
Isolation and culture of canine amniotic-fluid-derived
cells
Canine AF cells were characterized to MSCs by the
method described previously [31]. Briefly, canine AF was
collected from cesarean section by centesis under ultraso-
nographic guidance. The collected AF was centrifuged at
3,000 rpm for 10 min, and the pellet was washed twice
with phosphate-buffered saline (PBS, Gibco). Isolated AF
cells were seeded into a 60-mm culture dish containing
low-glucose Dulbecco’s modified Eagle medium (L-
DMEM) supplemented with 10 % fetal bovine serum
(FBS, Gibco), 5 ng/ml fibroblast growth factor (FGF),
10 ng/ml epidermal growth factor (EGF), and 0.1 % pen-
icillin–streptomycin (500 U/ml penicillin–5 mg/ml strep-
tomycin, P4458) at 39 C, 5 % carbon dioxide (CO2) in air
for 4–5 days.
Neural precursor differentiation of cAF-MSCs
For preneural differentiation, cAF-MSCs were cultured in
L-DMEM supplemented with 10 % FBS, 19 N2-supple-
ment (Gibco), 10 ng/ml FGF, 10 ng/ml EGF, and 0.1 %
penicillin–streptomycin. Two days after cultivation of
preneural differentiation, the preinduction media was
removed and cultured in L-DMEM supplemented with
0.5 % FBS, 1x N2 supplement, 1 mM N6.20-0-dibutyryl
cyclic adenosine monophosphate (db-cAMP), 200 lM
butylated hydroxyanisole (BHA), and 0.1 % penicillin–
streptomycin at 39 C, 5 % CO2 in air for 5 days.
Morphological analysis
To clearly observe cell phenotype, cAF-MSCs were
washed in PBS and stained using Diff-Quik kit (Sysmax
Corporation, Japan), as recommended by the manufac-
turer’s instructions. Briefly, cells were fixed by Diff-Quik
fixative solution and stained by Diff-Quik solution I and II.
The stained cells were observed using fluorescence
microscope (TE2000-U, Nikon, Japan).
RT-PCR analysis
Total RNA (tRNA) was extracted using RNA extract kit
(MACHEREY–NAGEL, Germany), as recommended by
the manufacturer’s instructions. RNA samples (1 lg
tRNA) were primed with oligo dT primer to synthesize
complementary DNA (cDNA) using iScript reverse trans-
criptase (Bio-Rad, USA). Real-time polymerase chain
reaction (RT-PCR) reaction cycle consisted of a 3-min
denaturation at 94 C, followed by 34 cycles at 94 C for
30 s, 60 C for 30 s, and 72 C for 30 s. A final extension
was completed at 72 C for 5 min, and RT-PCR reactions
were modified to 35 cycles with primer annealing at
58–60 C. RT-PCR-specific amplification of target genes
was confirmed by DNA sequencing. Results were evalu-
ated by Image J (National Institute of Health, USA) and
normalized to bII-microglobulin (b-MG). Primers are lis-
ted in Table 1.
Immunocytochemistry analysis
Cells were rinsed three times in PBS and fixed with 4 %
paraformaldehyde (4 g paraformaldehyde in 100 ml PBS) for
15 min, followed by permeabilization with 0.1 % Triton-X
100 in PBS for 20 min. Cells were then blocked and
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incubated in rabbit anti-nestin antibody (Abcam, MA, USA)
diluted 1:200, rabbit anti-bIII-tubulin antibody (Abcam)
diluted 1:200, and rabbit anti-tyrosine hydroxylase (TH)
antibody (Abcam) diluted 1:1000 in PBS containing 3 %
bovine serum albumin (BSA) overnight. Cells were washed
three times again in PBS containing 1 % Tween-20 and
incubated with secondary immunoglobulin (Ig)G rabbit anti-
body (Abcam) diluted 1:200 in blocking solution for 40 min
before final washing. The neuronal protein markers were
detected under a confocal laser-scanning microscope (LSM5
live configuration Vario Two VRGB), processed with elec-
tronics and computer module (Real Time control system), and
standard software (system configuration, ReUse function,
acquisition, Z-function multitracking, presentation, image
operation, fast-focusing system, etc.). At least ten fields of
view from three to five independent experiments were used to
count nestin, bIII-tubulin, and TH-positive cells: 400.6-Dia-
midino-2-phenylindole (DAPI, Life Technologies, CA, USA),
which has a high affinity specifically for DNA, was used for
nuclear staining to count total cell number.
Fluorescent-activated cell-sorter (FACS) analysis
Cells were harvested from the culture dish, centrifuged,
resuspended in PBS, and fixed with 4 % paraformaldehyde
and permeabilized with 0.1 % Triton-X 100. Neuronal cell
markers were detected by anti-rabbit nestin antibody, b-
tubulin III antibody, and TH antibody, followed by fluor-
escein-isothiocyanate-conjugated secondary antibody (Ab-
cam) diluted 1:100. Concentrations of nestin, b-tubulin III,
and TH antibody were described, as above. Results were
analyzed using the fluorescent-activated cell-sorter (FAC-
Scan) instrument operating with CELLQuest software
(Bencton Dickinson, USA).
Statistical analysis
Statistical data are presented as mean ± standard error of
the mean (SEM). Significant differences among samples
were determined using the JMP 10 statistics program (SAS
Institute, Inc., Cary, NC, USA). Comparisons for each pair
or all pairs were analyzed using Student’s t test or Tukey–
Kramer honestly significant difference test. Values of
P \ 0.05 were considered to be significantly different.
Result
Morphological changes on differentiation of cAF-
MSCs into neural precursor cell
In our previous report, we noted that cAF-MSCs can be
differentiated into adipocytes, osteocytes, and chondro-
cytes [31]. Moreover, according to FACS and immunocy-
tometry, cAF-MSCs express mesenchymal markers. In this
study, we used confirmed cAF-MSCs to estimate the
capacity of differentiation into neuronal precursor cells.
cAF-MSCs were induced for 5 days and morphological
change was confirmed. cAF-MSCs were prepared in basic
culture medium containing 10 % FBS prior to culture
(Fig. 1a, b). cAF-MSCs were first cultured for 2 days in
predifferentiation medium with N2 supplementation
(Fig. 1c) and for 3 days in final-differentiation medium
(Fig. 1d). After preinduction, cAF-MSCs began to change
morphologically into a spindle shape. Following final
neural induction, cAF-MSCs progressively acquired long
process extension and neuron-like morphology with a
dendritic shape.
Table 1 Real-time polymerase chain reaction (RT-PCR) primer sequences for canine-neural-specific genes
Gene Ref sequence Primer sequence (50-30) Annealing temperature (C) Size (bp)
NEFL NC_006607 Forward GAAGAAGCTGCCAAGGAAGA 58 202
Reverse GTTGACCTGATTTCGGGAGA
GFAP NC_006591 Forward ACCTGGCCAGTTATCGACAG 58 206
Reverse TCTTAGGGCTGCTGTGAGGT
NSE NC_006609 Forward GAGAACAGTGAAGCCTTGGA 60 298
Reverse ACCAATCTGGTTGACCTTGA
TUBB3 NC_006587 Forward GCACACTGCTCATCAACAAG 60 227
Reverse TCTTGCTCTCCTTCATGGAC
B2M NC_006612 Forward TCTACATTGGGCACTGTGTCAC 58 136
Reverse TGAAGAGTTCAGGTCTGACCAAG
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Expression levels of mRNA of neural specific genes
on neural cell differentiation
To determine whether cAF-MSCs were induced into neural
precursor cells, we tested expression levels of mRNA. RT-
PCR results indicated the expression of neural-specific genes,
such as NEFL, NSE, TUBB3, and the astrocyte-specific gene,
GFAP, in neuronal cAF-MSCs before (undifferentiation) and
after (differentiation) neural induction. Canine brain tissue
was used as a positive control. These genes showed little
detectable expression levels of mRNA in the neuronal
undifferentiated cAF-MSCs but were significantly increased
after induction of neural differentiation (Fig. 2a). Expression
levels of NEFL, GFAP, and TUBB3 mRNA were much
higher in brain tissue. To quantify expression levels of mRNA
of each gene, RT-PCR bands were calculated by Image J.
Expression level of NEFL, TUBB3, and NSE was signifi-
cantly increased after neural differentiation, even though
GFAP was not significantly increased (Fig. 2b). Results
showed very similar expression pattern between differenti-
ated cAF-MSCs and mature neural cells.
Expression levels of neural-specific proteins on neural-
cell differentiation
Neural-specific protein was analyzed in neuronal
undifferentiated and differentiated cAF-MSCs by
immunocytochemistry. Protein levels of neuronal-spe-
cific markers, such as nestin, bIII-tubulin, and the
dopamine neuronal-specific marker, TH, were not
expressed in neuronal undifferentiated cAF-MSCs
(Fig. 3a). However, protein levels of these markers
were dramatically expressed in neuronal differentiated
cAF-MSCs, even though TH was not strongly changed
in immunocytochemical staining pattern compared with
the expression level of undifferentiated cells (Fig. 3b).
Interestingly, expression levels of nestin and bIII-
tubulin protein were higher than TH in differentiated
cAF-MSCs. This result demonstrates that nestin, bIII-
tubulin, and TH were only expressed in the cytoplasm
and not in nuclei. Furthermore, differentiated neuronal
cells can be differentiated to dopamine-related neuro-
nal cells. This indicates that neuronal-specific peptide
and protein, as well as dopamine neuronal-specific
marker TH, were expressed in differentiated cAF-
MSCs.
Expression levels of nestin, bIII-tubulin, and TH in
differentiated cAF-MSCs were also confirmed after neural
differentiation by FACS analysis (Fig. 4). The neuronal-
differentiated cAF-MSCs have a greatly increased
expression of nestin (32 %), bIII-tubulin (70 %), and TH
(43 %) compared with controls (Table 2). After neural









cells. b Undifferentiated cAF-
MSCs stained with Diff-Quick.
c Spindle shape appeared in
cAF-MSCs 2 days after
induction of neural
differentiation. d By the end of
neuronal precursor
differentiation, cAF-MSCs were
stained with Diff-Quick solution
and could the progressively
acquire neuron-like
morphology, a large nucleus,
and long processes
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Discussion
In this study, we aimed to investigate whether MSCs
originating from cAF-MSC can differentiate into neural
precursor cells by identical neural induction reagent. By
using N2 supplementation as a neural growth factor, this
study was performed in two steps of induction protocol.
The first step was preinduction with serum, basic growth
factors, and N2 supplementation; the second step was
induction with db-cAMP, BHA, and N2 supplementation.
This two-step protocol is expected to reduce environmental
damage to cells following a change of medium supple-
mentation during induction of cell differentiation.
The intracellular cAMP level plays an important role in
the differentiation [12], increasing intracellular cAMP lev-
els, which activates the protein kinase A (PKA) signaling
pathway, finally affecting initiate neural differentiation [32].
Previous studies attempted to differentiate neural precursor
cells using various reagents, such as db-cAMP [12, 32, 33],
neural growth factor [34], brain-derived neural factor [12,
34], 3-isobutyl-1-methylxanthine [12, 32], retinoic acid [12,
32], sonic hedgehog homolog [12, 35], forskolin [36] and
2-mercaptoethanol (b-ME) [37].
The cAF-MSCs have proved their ability to differentiate
into neural cells, and in our study, these cells possess the
property of dopaminergic neurons. The cAF-MSCs differ-
entiated into neuronal precursor and dopaminergic neurons,
with this characteristic being identified though morphol-
ogy, RT-PCR, immunocytochemistry, and FACS analysis.
Dopamine, the catecholamine neurotransmitter, is an
important indicator in Parkinson’s diseases. Parkinson’s
disease is a progressively neurodegenerative disorder,
caused mainly by degenerating dopamine neurons in the
nigrostriatal pathway [38]. Therefore, replacement therapy
using dopamine neurons could be a potentially successful
treatment for patients with Parkinson’s disease [39, 40]. TH
is involved in the essential role of dopamine neuron
development and is expressed from the hypothalamus,
midbrain, brain stem, and olfactory bulb in the central
nervous system (CNS). All catecholamine neuron cells,
including dopamine neurons, highly express the TH gene,
which synthesizes catechol as a rate-limiting enzyme [12,
33]. The TH enzyme is also expressed in the amnion [41].
It suggested that amnion-derived stem cells, including AF-
MSCs, have the potential to be differentiated into dopa-




























































Fig. 2 Expression of neuron-
and astrocyte-specific markers.
a NEFL, NSE, TUBB3, and
GFAP were confirmed by real-
time polymerase chain reaction
(RT-PCR). bII microglobulin
[b-MG (B2M)] and brain tissue
were used as a housekeeping
gene and positive control,
respectively. b The intensity of
messenger RNA (mRNA)
expression levels of each gene
was quantified and normalized
to b-MG
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express some neuronal lineage markers, such as neuron,
ganglia, catecholamine, dopamine, and neurotrophic fac-
tors [23, 42, 43]. These results mean that AF is ready to use
as a potential source for the induction of neuronal cells and
functional dopaminergic neurons.
The astrocyte, one of three major cell type of the CNS,
plays an important role as a supporting neuronal cell. In
neuronal and brain injury; however, astrocytes active pro-
liferation rate and changes to the form of reactive gliosis
[44]. Pathologically, these astrocytic changes contributed
to progression of neuronal degeneration and inflammation,
causing neuron degeneration disease [45]. Therefore,
inflammatory reaction, such as the occurrence of macro-
phages and microglia, is related to treatment of neuronal
degenerative diseases [46–48]. Analysis using mRNA
shows that expression of neuronal-specific genes on neu-
ronal-cell differentiation and GFAP expression level was
not significantly increased. Therapeutically, low GFAP
expression in undifferentiated and differentiated cAF-
MSCs is considered an advantage to this potential source of
cell transplantation therapy.
This study demonstrates that cAF-MSCs have the
ability to effectively differentiate into neural precursor
cells and that cAF-MSCs can be induced into dopamine
neuron-like cells with db-cAMP and BHA treatment.









Fig. 3 Immunocytochemistry analysis for expression of neuronal-
cell-specific markers, such as nestin, bIII-tubulin, and dopamine
neuronal-specific marker, tyrosine hydroxylase (TH). Immunocyto-
chemistry was performed in canine amniotic fluid mesenchymal stem
cells (cAF-MSCs), which were a undifferentiated and b differentiated.
All neuronal-specific markers were detected in the cytoplasm of
differentiated cells, and the nucleus WAS stained by 400.6-
Diamidino-2-phenylindole (DAPI). Magnification= 9100
Fig. 4 Analysis of expression of neural-specific makers on differen-
tiated neuronal canine amniotic fluid mesenchymal stem cells (cAF-
MSCs). Induced neural cAF-MSCs were collected, and III-tubulin,
nestin, and tyrosine hydroxylase (TH) expression on their surfaces
was measured by flow cytometry. cAF-MSCs: green-filled histograms
represent staining with isotype-matched antibody
Table 2 Fluorescent-activated cell-sorter (FACS) analysis for
expressed proportion of neuronal-cell and dopamine neuronal-cell-
specific markers, such as bIII-tubulin, nestin, and tyrosine hydroxy-
lase (TH). The value of each expression level was evaluated after
induction
Control bIII-tubulin Nestin TH
Expression (%) 1.2 69.7 32.22 43.04
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MSCs with a fibroblast-like shape changed to neural-like
cells, with long processes, growth cone, dendritic pro-
cesses, and neuron-network-like structures, as noted in
the previous studies [18, 23]. By analyzing protein
expression using immunocytochemistry, we corrobo-
rated the differentiation potential of cAF-MSCs. These
results clearly show that cAF-MSCs could be differen-
tiated into functional neuron precursor cells, in contrast
with previous studies [1, 32, 34]. FACS analysis also
shows that neural-induced cAF-MSCs indicate the con-
siderable differentiation potential of nestin (32.22 %),
bIII-tubulin (69.74 %), and TH (43.04 %).
In conclusion, cAF-MSCs were successfully differenti-
ated into neuronal precursor and dopaminergic neurons at the
same time by one neural induction method, with distinction
of another method for dopaminergic induction. This study
supports the potential capacity of cAF-MSCs for clinical
treatment of neuronal precursor-cell transplantation.
Acknowledgments This work was supported by grant of the
Cooperative Research Program for Agriculture Science and Tech-
nology Development (Project No. PJ009333) Rural Development
Administration, Republic of Korea, and a grant (110056-3) from the
Korea Institute of Planning and Evaluation for Technology (iPET),
Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
Korea.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Montzka K, Lassonczyk N, Tscho¨ke B, Neuss S, Fu¨hrmann T,
Franzen R, Smeets R, Brook GA, Wo¨ltje M. Neural differentia-
tion potential of human bone marrow-derived mesenchymal
stromal cells: misleading marker gene expression. BMC Neuro-
sci. 2009;. doi:10.1186/1471-2202-10-16.
2. Seo MS, Jeong YH, Park JR, Park SB, Rho KH, Kim HS, Yu KR,
Lee SH, Jung JW, Lee YS, Kang KS. Isolation and character-
ization of canine umbilical cord blood-derived mesenchymal
stem cells. J Vet Sci. 2009;10:181–7.
3. Sago K, Tamahara S, Tomihari M, Matsuki N, Asahara Y, Takei
A, Bonkobara M, Washizu T, Ono K. In vitro differentiation of
canine celiac adipose tissue-derived stromal cells into neuronal
cells. J Vet Med Sci. 2008;70:353–7.
4. Hayes B, Fagerlie SR, Ramakrishnan A, Baran S, Harkey M, Graf
L, Bar M, Bendoraite A, Tewari M, Torok-Storb B. Derivation,
characterization, and in vitro differentiation of canine embryonic
stem cells. Stem Cells. 2008;26:465–73.
5. Schneider MR, Wolf E, Braun J, Kolb HJ, Adler H. Canine
embryo-derived stem cells and models for human diseases. Hum
Mol Genet. 2008;. doi:10.1093/hmg/ddn078.
6. Tsai KL, Clark LA, Murphy KE. Understanding hereditary dis-
eases using the dog and human as companion model systems.
Mamm Genome. 2007;18:444–51.
7. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe
DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ 3rd, Lander ES.
Genome sequence, comparative analysis and haplotype structure
of the domestic dog. Nature. 2005;438:803–19.
8. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow
osteogenic stem cells: in vitro cultivation and transplantation in
diffusion chambers. Cell Tissue Kinet. 1987;20:263–72.
9. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-
Guzma´n P, Herna´ndez-Este´vez E, Fajardo-Ordun˜a G, Orozco S,
Mayani H. Human mesenchymal stromal cells from adult and
neonatal sources: comparative analysis of their morphology,
immunophenotype, differentiation patterns and neural protein
expression. Cytotherapy. 2009;11:163–76.
10. Paniushin OV, Domaratskaia EI, Starostin VI. Mesenchymal
stem cells: sources, phenotype, and differentiation potential. lzv
Akad Nauk Ser Biol. 2006;(1):6–25.
11. Chen L, He DM, Zhang Y. The differentiation of human pla-
centa-derived mesenchymal stem cells into dopaminergic cells
in vitro. Cell Mol Biol Lett. 2009;14:528–36.
12. Barzilay R, Kan I, Ben-Zur T, Bulvik S, Melamed E, Offen D.
Induction of human mesenchymal stem cells into dopamine-
producing cells with different differentiation protocols. Stem
Cells Dev. 2008;17:547–54.
13. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin
L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME,
Soker S, Atala A. Isolation of amniotic stem cell lines with
potential for therapy. Nat Biotechnol. 2007;25:100–6.
14. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J,
Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala
A, De Filippo RE, Warburton D. Human amniotic fluid stem cells
can integrate and differentiate into epithelial lung lineages. Stem
Cells. 2008;26:2902–11.
15. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res
Clin Obstet Gynaecol. 2004;18:877–91.
16. Mareschi K, Rustichelli D, Comunanza V, De Fazio R, Cravero
C, Morterra G, Martinoglio B, Medico E, Carbone E, Benedetto
C, Fagioli F. Multipotent mesenchymal stem cells from amniotic
fluid originate neural precursors with functional voltage-gated
sodium channels. Cytotherapy. 2009;11:534–47.
17. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human
amniotic epithelial cells possess hepatocyte-like characteristics
and functions. Cell Struct Funct. 2004;29:73–84.
18. Tamagawa T, Ishiwata I, Ishikawa H, Nakamura Y. Induced
in vitro differentiation of neural-like cells from human amnion-
derived fibroblast-like cells. Hum Cell. 2008;21:38–45.
19. Lim JH, Byeon YE, Ryu HH, Jeong YH, Lee YW, Kim WH,
Kang KS, Kweon OK. Transplantation of canine umbilical cord
blood-derived mesenchymal stem cells in experimentally induced
spinal cord injured dogs. J Vet Sci. 2007;8:275–82.
20. Tropel P, Platet N, Platel JC, Noe¨l D, Albrieux M, Benabid AL,
Berger F. Functional neuronal differentiation of bone marrow-
derived mesenchymal stem cells. Stem Cells. 2006;24:2868–76.
21. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human
amniotic mesenchymal cells have some characteristics of
cardiomyocytes. Transplantation. 2005;79:528–35.
22. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T. Human
amnion-isolated cells normalize blood glucose in streptozotocin-
induced diabetic mice. Cell Transplant. 2003;12:545–52.
23. Pfeiffer S, McLaughlin D. In vitro differentiation of human
amniotic fluid-derived cells: augmentation towards a neuronal
dopaminergic phenotype. Cell Biol Int. 2010;34:959–67.
24. Portmann-Lanz CB, Schoeberlein A, Portmann R, Mohr S, Rollini P,
Sager R, Surbek DV. Turning placenta into brain: placental mes-
enchymal stem cells differentiate into neurons and oligodendrocytes.
Am J Obstet Gynecol. 2010;. doi:10.1016/j.ajog.2009.10.893.
25. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of
amniotic membrane/amnion-derived cells for regeneration of
various tissues. J Pharmacol Sci. 2007;105:215–28.
Neuronal cell differentiation from mesenchymal stem cells 57
123
26. Esposito E, Genovese T, Caminiti R, Bramanti P, Meli R, Cu-
zzocrea S. Melatonin reduces stress-activated/mitogen-activated
protein kinases in spinal cord injury. J Pineal Res.
2009;46:79–86.
27. Ryu HH, Lim JH, Byeon YE, Park JR, Seo MS, Lee YW, Kim
WH, Kang KS, Kweon OK. Functional recovery and neural dif-
ferentiation after transplantation of allogenic adipose-derived
stem cells in a canine model of acute spinal cord injury. J Vet Sci.
2009;10:273–84.
28. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchy-
mal stem cell tissue engineering: techniques for isolation,
expansion and application. Injury. 2007;38(Suppl 4):S23–33.
29. Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of
mesenchymal stem cells: a critical review. APMIS. 2005;113:
831–44.
30. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford
T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N,
Cooper DR, Sanberg PR. Adult bone marrow stromal cells dif-
ferentiate into neural cells in vitro. Exp Neurol. 2000;164:
247–56.
31. Choi SA, Choi HS, Kim KJ, Lee DS, Lee JH, Park JY, Kim EY,
Li X, Oh HY, Lee DS, Kim MK. Isolation of canine mesen-
chymal stem cells from amniotic fluid and differentiation into
hepatocyte-like cells. In Vitro Cell Dev Biol Anim.
2013;49:42–51.
32. Tio M, Tan KH, Lee W, Wang TT, Udolph G. Roles of db-
cAMP, IBMX and RA in aspects of neural differentiation of cord
blood derived mesenchymal-like stem cells. PLoS One.
2010;5(2):e9398. doi:10.1371/journal.pone.0009398.
33. Tremblay RG, Sikorska M, Sandhu JK, Lanthier P, Ribecco-
Lutkiewicz M, Bani-Yaghoub M. Differentiation of mouse neuro
2A cells into dopamine neurons. J Neurosci Methods. 2009;186:
60–7.
34. Kamishina H, Cheeseman JA, Clemmons RM. Nestin-positive
spheres derived from canine bone marrow stromal cells generate
cells with early neuronal and glial phenotypic characteristics.
In Vitro Cell Dev Biol Anim. 2008;44:140–4.
35. Trzaska KA, Kuzhikandathil EV, Rameshwar P. Specification of
a dopaminergic phenotype from adult human mesenchymal stem
cells. Stem Cells. 2007;25:2797–808.
36. Jang S, Cho HH, Cho YB, Park JS, Jeong HS. Functional neural
differentiation of human adipose tissue-derived stem cells using
bFGF and forskolin. BMC Cell Biol. 2010;. doi:10.1186/1471-
2121-11-25.
37. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and
human bone marrow stromal cells differentiate into neurons.
J Neurosci Res. 2000;61:364–70.
38. Foti R, Zucchelli S, Biagioli M, Roncaglia P, Vilotti S, Calligaris
R, Krmac H, Girardini JE, Del Sal G, Gustincich S. Parkinson
disease-associated DJ-1 is required for the expression of the glial
cell line-derived neurotrophic factor receptor RET in human
neuroblastoma cells. J Biol Chem. 2010;285:18565–74.
39. Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke
YQ, He XY, Jin ZL, Lu GH, Su DQ. Human umbilical vein-
derived dopaminergic-like cell transplantation with nerve growth
factor ameliorates motor dysfunction in a rat model of Parkin-
son’s disease. Neurochem Res. 2010;35:1522–9.
40. Winner B, Desplats P, Hagl C, Klucken J, Aigner R, Ploetz S,
Laemke J, Karl A, Aigner L, Masliah E, Buerger E, Winkler J.
Dopamine receptor activation promotes adult neurogenesis in an
acute Parkinson model. Exp Neurol. 2009;219:543–52.
41. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S,
Kamo I, Kobayashi M, Yokoyama Y. Human amnion mesen-
chyme cells express phenotypes of neuroglial progenitor cells.
J Neurosci Res. 2004;78:208–14.
42. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N.
Human amniotic epithelial cells produce dopamine and survive
after implantation into the striatum of a rat model of Parkinson’s
disease: a potential source of donor for transplantation therapy.
Exp Neurol. 2000;165:27–34.
43. Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M,
Sakuragawa N. Neurotrophic function of conditioned medium
from human amniotic epithelial cells. J Neurosci Res. 2000;
62:585–90.
44. Amanda K, William H, Takeshi K, Julie A, Ashley P, Ronald B,
Marie E. Analysis of targeted mutation in DJ-1 on cellular
function in primary astrocytes. Toxicol Lett. 2009;184:186–91.
45. Park SS, Byeon YE, Ryu HH, Kang BJ, Kim Y, Kim WH, Kang
KS, Han HJ, Kweon OK. Comparison of canine umbilical cord
blood-derived mesenchymal stem cell transplantation times:
involvement of astrogliosis, inflammation, intracellular actin
cytoskeleton pathways, and neurotrophin-3. Cell Transpl.
2011;20:1867–80.
46. Davies SJ, Shih CH, Noble M, Mayer-Proschel M, Davies JE,
Proschel C. Transplantation of specific human astrocytes pro-
motes functional recovery after spinal cord injury. PLoS ONE.
2011;. doi:10.1371/journal.pone.0017328.
47. Kim H, Zahir T, Tator CH, Shoichet MS. Effects of dibutyryl
cyclic-AMP on survival and neuronal differentiation of neural
stem/progenitor cells transplanted into spinal cord injured rats.
PLoS ONE. 2011;. doi:10.1371/journal.pone.0021744.
48. Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle DD,
Yallapragada AV, Reiter RJ, Ray SK, Banik NL. Melatonin
attenuates calpain upregulation, axonal damage and neuronal
death in spinal cord injury in rats. J Pineal Res. 2008;2008(44):
348–57.
58 E. Y. Kim et al.
123
